期刊文献+

同时性结肠直肠癌切除和肝转移病灶手术时机的荟萃分析 被引量:4

Outcome of simultaneous vs staged resections for colorectal cancerand its liver metastasis (metastases):a meta-analysis
下载PDF
导出
摘要 目的:探讨同时性结肠直肠癌切除和肝转移病灶的最佳手术时机选择。方法:通过检索电子数据库,对1966年至2009年结肠直肠癌和肝转移灶行同期或分期切除的对照研究资料进行荟萃分析。结果:共纳入14篇文献,2 204例病人。荟萃分析结果显示,同期切除组与分期切除组比较,手术时间和术中出血方面两组间均无统计学差异(P>0.05);同期切除组住院时间较短(P<0.01),手术相关并发症率较低(P<0.01),差异有统计学意义。两者在术后1年、3年和5年生存率方面均无统计学差异(P>0.05)。结论:与分期切除相比,同时性行结肠直肠癌和肝转移灶切除同样安全、有效。 Objective The aim of this meta-analysis is to compare the outcome between simultaneous and staged resections of the primary tumor and its liver metastasis(es) from all published studies in the literature.Methods Databases from Pubmed,medline,Embase,Cochrane Library,Ovid and Web of Science,were searched to compare the outcome following simultaneous resections with staged resections for SCLM.The meta-analysis was performed by RevMan 4.2.Results Fourteen comparative studies comprising 2204 patients were studied.Patients undergoing simultaneous resections were found to experience similar operative time and intra-operative blood loss(P〉0.05).A shorter hospital stay(P〈0.01) and a lower morbidity rate(P〈0.01) were observed in the simultaneous resections group.The survival rate in the simultaneous resections group did not statistically differ with that of the staged resections group at 1 year,3 years and 5 years(P〉0.05) post-operative respectively.Conclusions Simultaneous resections are safe and efficient in the treatment of patients with SCLM while avoiding a second major operation.In appropriately selected patients,simultaneous resections might be considered as the preferred approach.
出处 《外科理论与实践》 2010年第4期369-374,共6页 Journal of Surgery Concepts & Practice
关键词 结肠直肠肿瘤 肿瘤转移 肝切除术 荟萃分析 Colorectal carcinoma Metastases Hepatectomy Meta-analysis
  • 相关文献

参考文献1

二级参考文献1

共引文献7

同被引文献52

  • 1LeGolvan MP, Resnick M. Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. J Surg Oncol, 2010, 102(8) : 898-908.
  • 2Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg, 2005, 241(5 ) : 715-722.
  • 3Martin RC 2nd, Augenstein V, Ranter NP, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coil Surg, 2009,208 (5) : 842-850.
  • 4Mansfield SD, Scott J, Oppong K, et al. Comparison of multislice computed tomography and endoscopic uhrasonography with operative and histological findings in suspected pancreatic and periampullary malignancy.Br J Surg, 2008, 95(12) : 1512-1520.
  • 5Arnold D,Schmoll H J, Lang H, et al. Specific treatment situations in metastatic colorectal cancer. Onkologie, 2010,33 Suppl 4: $8-18.
  • 6Benoist S, Bmuquet A, Penna C, et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol, 2006, 24(24): 3939-3945.
  • 7Welch S, Spithoff K, Rumble RB, et al. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer:asystematic review. Ann Oncol, 2010, 21(6) : 1152-1162.
  • 8Raoul JL, van Laethem JL, Peeters M, et al. Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIR1) in the initial treatment of metastatic colorectal cancer: a multiicentre two-part phase Ⅰ / Ⅱ study. BMC cancer, 2009, 9 : 112.
  • 9Makatsoris T, Kalofonos HP, Aravantinos G, et al. A phase Ⅱstudy of capecitabine plus oxaliplatin (XELOX) : a new first-line option in metastatic colorectal cancer. Int J Gastrointest Cancer, 2005, 35(2): 103-109.
  • 10Tabernero J, van Cutsem E, D t az-Rubio E, et al. Phase Ⅱ trial of cetuximab in combination with fluo rouracil, leucovorin,and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol, 2007, 25 (33) : 5225-5232.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部